6Swain SM,Whaley FS,Ewer MS,et al.Congestive heart failure in patients treated with doxorubicin:a retrospective analysis of three trials[J].Cancer,2003,97 (11):2869-2879. 被引量：1
7Ganame J,Claus P,Uyttebroeck A,et al.Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients[J].J Am Soc Echocardiogr,2007,20(12):1351-1358. 被引量：1
9Lipshultz SE,Rifai N,Sallan SE,et al.Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury[J].Circulation,1997,96(8):2641-2648. 被引量：1
10Minotti G,Menna P,Salvatorelli E,et al.Anthracyclines:molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity[J].Pharmacol Rev,2004,56 (2):185-229. 被引量：1
7Germanakis I, Kalmanti M, Parthenakis F, et al. Correlation of plasma N-terminal pro-brain natriuretic peptide level with left ventricle mass in children treated with anthracyclines[ J]. Int J Cardiol,2006,108:212 -215. 被引量：1
8Malty M, Espie M, Llombart A, et al. Muhicenter randomized Phase Ⅲ study of the cardioprotective effect of dexrazoxane in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy[ J]. Ann Onco1,2006 ,17 :614 - 622. 被引量：1
9Sterba M, Popelova O, Simunek T, et al. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH) [ J ]. Toxicology ,2007,253 ( 3 ) : 150 - 166. 被引量：1
10Kaiserva H, Simunek T, van der Vijgh W J, et al. Flavonoids as protectors against doxorubicin cardiotoxicity : role of iron chelation, an-tioxidant activity and inhibition of carbonyl reductase [ J ]. Biochim Biophys Acta,2007,1772 : 1065 - 1074. 被引量：1
